Cardiovascular Disease Risk in Women With Endometriosis

Recruiting now · Early Phase 1

Conditions studied: Endometriosis

In brief

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

Key facts

Study ID

NCT03746535

Run by

Yale University

People needed

40

Starts

2022-07-01

Expected to finish

2026-12-31

Last updated by the study team

2025-05-23

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Young women between the ages of 18 and 45 years (Controls);
• Young women between the ages of 18 and 45 years with endometriosis.

You may not qualify if…

• Subjects who smoke
• Subjects who have diabetes,
• Subjects with sleep apnea or BP>140/90 will be excluded.
• Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.

Where it is running

• Yale School of Medicine — New Haven, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.